Stephen Chan
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial.
Wildiers H, Armstrong A, Cuypere E, Dalenc F, Dirix L, Chan S, Marme F, Schröder C, Huober J, Duhoux F, Vuylsteke P, Jager A, Brain E, Kümmel S, Pápai Z, Menke-van der Houven van Oordt C, Perjesi L, Mueller A, Brignone C, Triebel F. Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial. Clin Cancer Res 2023
Nov 8, 2023Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial.
Nov 8, 2023Clin Cancer Res 2023
Wildiers Hans, Armstrong Anne, Cuypere Eveline, Dalenc Florence, Dirix Luc, Chan Stephen, Marme Frederik, Schröder Carolina P, Huober Jens, Duhoux Francois P, Vuylsteke Peter, Jager Agnes, Brain Etienne, Kümmel Sherko, Pápai Zsuzsanna, Menke-van der Houven van Oordt Catharina Willemien, Perjesi Luca, Mueller Arndt-Christian, Brignone Chrystelle, Triebel Frederic
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Chan S, Frimodt-Moller B, Vaury A, Carrasco E, Jones A, Harrison M, Antón A, Mayordomo J, Kreienberg R, du Bois A, Llombart A, Lluch A, Schneeweiss A, Tubiana-Hulin M, Delozier T, Huober J, Romieu G, Fumoleau P. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60.
Apr 10, 2009Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Apr 10, 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60
Chan Stephen, Frimodt-Moller Bente, Vaury A Thareau, Carrasco Eva, Jones Alison, Harrison Mark, Antón Antonio, Mayordomo Jose Ignacio, Kreienberg Rolf, du Bois Andreas, Llombart Antonio, Lluch Ana, Schneeweiss Andreas, Tubiana-Hulin Michele, Delozier Thierry, Huober Jens, Romieu Gilles, Fumoleau Pierre